Stage Specialty Pharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Stage Specialty Pharmaceutical stocks.

Stage Specialty Pharmaceutical Stocks Recent News

Date Stock Title
Nov 20 ACRS Aclaris upgraded to overweight by Cantor on in-licensing deal
Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
Nov 19 ACRS Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
Nov 19 ACRS Aclaris stock soars for second day on licensing deal, analyst upgrades
Nov 19 ACRS Aclaris Therapeutics secures global rights to Biosion’s antibodies
Nov 19 ACRS ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
Nov 18 ACRS Aclaris stock rallies 53% amid licensing deal, Piper upgrade
Nov 18 TNXP Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
Nov 18 ACRS Aclaris signs license deal for biologics assets
Nov 18 ACRS Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
Nov 18 ACRS Aclaris Therapeutics Announces $80 Million Private Placement
Nov 18 ACRS Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
Nov 18 TNXP Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Nov 17 SLGL Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations
Nov 15 SLGL Sol-Gel Technologies GAAP EPS of -$0.01 beats by $0.04, revenue of $5.36M beats by $1.16M
Nov 15 CPRX Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
Nov 15 SLGL Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
Nov 15 SLGL Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Stage Specialty Pharmaceutical

Stage Specialty Pharmaceuticals is a specialty pharmaceutical company that focuses on developing and commercializing innovative treatments for rare and complex diseases. The company works with leading healthcare providers, payers, and patient advocacy groups to develop and deliver treatments that improve the lives of patients. Stage Specialty Pharmaceuticals is committed to providing access to treatments that are safe, effective, and affordable.

Browse All Tags